Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 4.0M | 1.9M | 9.0M | 20.0M |
| Operating Revenue | 4.0M | 1.9M | 9.0M | 20.0M |
| Cost Of Revenue | 4.8M | 3.9M | 5.1M | 12.6M |
| Gross Profit | -792,000 | -2.0M | 3.9M | 7.4M |
| Selling General And Administration | 16.5M | 13.8M | 12.6M | 9.7M |
| General And Administrative Expense | 16.5M | 13.8M | 12.5M | 9.7M |
| Other Operating Expenses | 46.0M | 33.1M | 27.8M | 21.0M |
| Operating Expense | 62.5M | 46.9M | 40.4M | 30.7M |
| Operating Income | -63.3M | -48.9M | -36.5M | -23.3M |
| EBIT | -91.7M | 87.1M | 10.4M | 20.1M |
| Interest Expense | 108,000 | 52,000 | 60,000 | 3.2M |
| Interest Expense Non Operating | 108,000 | 52,000 | 60,000 | 3.2M |
| Interest Income | 7.7M | 4.2M | 1.4M | 383,000 |
| Interest Income Non Operating | 7.7M | 4.2M | 1.4M | 383,000 |
| Net Interest Income | 4.6M | 619,000 | -1.4M | -2.8M |
| Other Income Expense | -33.1M | 135.3M | 48.2M | 43.1M |
| Other Non Operating Income Expenses | 5.0M | 3.8M | 5.8M | -187,000 |
| Special Income Charges | 162,000 | 1.3M | -25,000 | 135,000 |
| Gain On Sale Of Security | -38.3M | 134.6M | 45.4M | 43.6M |
| Earnings From Equity Interest | 16,000 | -4.4M | -2.9M | -464,000 |
| Pretax Income | -91.8M | 87.0M | 10.3M | 17.0M |
| Tax Provision | -236,000 | -2.3M | -2.3M | -2.0M |
| Tax Effect Of Unusual Items | -97,938 | 54.4M | 11.9M | 11.6M |
| Net Income From Continuing And Discontinued Operation | -91.1M | 90.4M | 14.4M | 19.0M |
| Net Income From Continuing Operation Net Minority Interest | -91.6M | 89.4M | 12.6M | 19.0M |
| Net Income Including Noncontrolling Interests | -91.1M | 90.4M | 14.4M | 19.0M |
| Net Income Common Stockholders | -91.1M | 90.4M | 14.4M | 19.0M |
| Net Income | -91.1M | 90.4M | 14.4M | 19.0M |
| EBITDA | -81.8M | 96.5M | 19.0M | 27.5M |
| Normalized EBITDA | -43.7M | -39.5M | -26.3M | -16.2M |
| Reconciled Depreciation | 9.9M | 9.4M | 8.7M | 7.4M |
| Basic EPS | -0.10 | 0.11 | 0.02 | 0.02 |
| Diluted EPS | -0.10 | 0.10 | 0.02 | 0.02 |
| Basic Average Shares | 892.2M | 848.0M | 818.9M | 783.7M |
| Diluted Average Shares | 892.2M | 854.0M | 828.7M | 793.7M |
| Total Unusual Items | -38.1M | 135.9M | 45.3M | 43.8M |
| Total Unusual Items Excluding Goodwill | -38.1M | 135.9M | 45.3M | 43.8M |
| Tax Rate For Calcs | 0.00 | 0.40 | 0.26 | 0.27 |
| Normalized Income | -53.6M | 7.8M | -20.9M | -13.2M |
| Diluted NI Availto Com Stockholders | -91.1M | 90.4M | 14.4M | 19.0M |
| Gain On Sale Of Ppe | 162,000 | 1.3M | -25,000 | 135,000 |
| Net Income Continuous Operations | -91.6M | 89.4M | 12.6M | 19.0M |
| Net Income Discontinuous Operations | 471,000 | 1.0M | 1.8M | -- |
| Net Non Operating Interest Income Expense | 4.6M | 619,000 | -1.4M | -2.8M |
| Other Gand A | 16.5M | 13.8M | 12.5M | 9.7M |
| Reconciled Cost Of Revenue | 4.8M | 3.9M | 5.1M | 12.6M |
| Selling And Marketing Expense | -- | 0.00 | 48,000 | 0.00 |
| Total Expenses | 67.3M | 50.8M | 45.5M | 43.3M |
| Total Other Finance Cost | 3.1M | 3.5M | 2.8M | -- |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 108.5M | 131.1M | 50.9M | 64.0M |
| Cash Cash Equivalents And Short Term Investments | 114.8M | 141.5M | 58.9M | 78.4M |
| Cash Equivalents | 104.4M | 127.4M | 47.9M | 60.7M |
| Cash Financial | 4.1M | 3.7M | 3.1M | 3.3M |
| Other Short Term Investments | 6.3M | 10.4M | 8.0M | 14.4M |
| Accounts Receivable | 3.1M | 1.9M | 3.2M | 2.9M |
| Receivables | 3.1M | 1.9M | 4.1M | 3.7M |
| Inventory | 3.7M | 3.6M | 2.7M | 3.5M |
| Prepaid Assets | -- | -- | -- | 1.3M |
| Other Current Assets | 2.1M | 1.6M | 1.4M | 1.3M |
| Current Assets | 123.7M | 148.5M | 67.2M | 86.9M |
| Gross PPE | 302.7M | 294.3M | 289.1M | 286.4M |
| Accumulated Depreciation | -43.1M | -39.3M | -35.5M | -32.0M |
| Net PPE | 259.7M | 254.9M | 253.5M | 254.5M |
| Investments And Advances | 266.5M | 309.8M | 181.9M | 154.6M |
| Long Term Equity Investment | 20.7M | 17.3M | 19.3M | 21.4M |
| Other Investments | 231.1M | 276.8M | 162.5M | 133.1M |
| Other Non Current Assets | 13.7M | 13.3M | 13.2M | 14.1M |
| Total Non Current Assets | 539.9M | 578.1M | 448.6M | 423.4M |
| Total Assets | 663.6M | 726.6M | 515.8M | 510.3M |
| Accounts Payable | 13.3M | 5.0M | 5.4M | 3.5M |
| Payables | 21.3M | 10.8M | 10.3M | 8.6M |
| Payables And Accrued Expenses | 21.3M | 10.8M | 10.3M | 8.6M |
| Current Deferred Revenue | 4.5M | 4.5M | 4.9M | 4.7M |
| Other Current Liabilities | 6.3M | 333,000 | 336,000 | 1.8M |
| Current Liabilities | 33.9M | 17.9M | 18.4M | 16.4M |
| Other Non Current Liabilities | 2.9M | 1.2M | 1.4M | 329,000 |
| Total Non Current Liabilities Net Minority Interest | 65.4M | 66.9M | 61.4M | 97.2M |
| Total Liabilities Net Minority Interest | 99.3M | 84.8M | 79.8M | 113.6M |
| Common Stock | 1.7B | 1.7B | 1.5B | 1.5B |
| Capital Stock | 1.7B | 1.7B | 1.5B | 1.5B |
| Additional Paid In Capital | 73.3M | 69.8M | 70.3M | 67.5M |
| Retained Earnings | -1.2B | -1.1B | -1.2B | -1.2B |
| Gains Losses Not Affecting Retained Earnings | 1.8M | 1.8M | 1.8M | 1.8M |
| Other Equity Adjustments | 1.8M | 1.8M | 1.8M | 1.8M |
| Common Stock Equity | 564.3M | 641.8M | 436.0M | 396.7M |
| Stockholders Equity | 564.3M | 641.8M | 436.0M | 396.7M |
| Total Equity Gross Minority Interest | 564.3M | 641.8M | 436.0M | 396.7M |
| Total Capitalization | 564.3M | 641.8M | 436.0M | 396.7M |
| Net Tangible Assets | 564.3M | 641.8M | 436.0M | 396.7M |
| Tangible Book Value | 564.3M | 641.8M | 436.0M | 396.7M |
| Working Capital | 89.8M | 130.6M | 48.7M | 70.5M |
| Invested Capital | 564.3M | 641.8M | 436.0M | 396.7M |
| Share Issued | 895.7M | 891.0M | 826.3M | 812.4M |
| Ordinary Shares Number | 895.7M | 891.0M | 826.3M | 812.4M |
| Available For Sale Securities | 1.8M | 117,000 | 87,000 | 141,000 |
| Current Deferred Liabilities | 4.5M | 4.5M | 4.9M | 4.7M |
| Current Provisions | 1.7M | 2.3M | 2.9M | 1.2M |
| Derivative Product Liabilities | -- | -- | 0.00 | 20.3M |
| Duefrom Related Parties Current | -- | 623,000 | 508,000 | 533,000 |
| Dueto Related Parties Current | 7.0M | 4.8M | 4.0M | 4.3M |
| Employee Benefits | -- | -- | 1.1M | 1.2M |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | -- | -- | -- | 141,000 |
| Finished Goods | -- | -- | 0.00 | 451,000 |
| Held To Maturity Securities | 13.0M | 15.6M | 0.00 | -- |
| Investmentin Financial Assets | 14.8M | 15.7M | 87,000 | 141,000 |
| Investmentsin Joint Venturesat Cost | 20.7M | 17.3M | 19.3M | 21.4M |
| Long Term Provisions | 30.6M | 32.6M | 26.6M | 36.4M |
| Machinery Furniture Equipment | 118.6M | 113.5M | 108.8M | 106.6M |
| Non Current Deferred Liabilities | 31.9M | 33.0M | 33.3M | 39.1M |
| Non Current Deferred Revenue | 29.5M | 30.4M | 28.4M | 31.9M |
| Non Current Deferred Taxes Liabilities | 2.4M | 2.6M | 5.0M | 7.2M |
| Non Current Pension And Other Postretirement Benefit Plans | -- | -- | 1.1M | 1.2M |
| Non Current Prepaid Assets | -- | -- | 0.00 | 221,000 |
| Other Payable | 1.0M | 942,000 | 829,000 | 822,000 |
| Other Receivables | -- | 27,000 | 23,000 | 2,000 |
| Pensionand Other Post Retirement Benefit Plans Current | -- | -- | 120,000 | 120,000 |
| Raw Materials | -- | 3.6M | 2.7M | 3.0M |
| Taxes Receivable | -- | 364,000 | 428,000 | 255,000 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -40.4M | -30.7M | -28.1M | -21.2M |
| Cash Flow From Continuing Operating Activities | -40.4M | -30.7M | -28.1M | -21.2M |
| Depreciation Amortization Depletion | 9.9M | 9.4M | 8.7M | 7.4M |
| Stock Based Compensation | 4.7M | 3.7M | 3.7M | 2.8M |
| Deferred Tax | -236,000 | -2.3M | -2.3M | -2.0M |
| Deferred Income Tax | -236,000 | -2.3M | -2.3M | -2.0M |
| Change In Working Capital | 7.7M | 1.9M | 1.7M | -199,000 |
| Change In Receivables | -823,000 | 2.2M | -512,000 | -282,000 |
| Change In Inventory | -165,000 | -866,000 | 741,000 | -410,000 |
| Change In Payables And Accrued Expense | 9.2M | 759,000 | 1.4M | 676,000 |
| Other Non Cash Items | -8.5M | -1.8M | -11.6M | -4.7M |
| Capital Expenditure | -7.7M | -3.2M | -6.9M | -1.2M |
| Purchase Of PPE | -7.7M | -3.2M | -6.9M | -1.2M |
| Net PPE Purchase And Sale | -7.5M | -3.1M | -6.9M | -1.1M |
| Purchase Of Business | -5.3M | -2.4M | -800,000 | -1.4M |
| Purchase Of Investment | 0.00 | -15.0M | 0.00 | -91.7M |
| Sale Of Investment | 13.6M | 19.9M | 0.00 | 15.6M |
| Net Investment Purchase And Sale | 13.6M | 4.9M | 0.00 | -76.1M |
| Investing Cash Flow | 426,000 | -719,000 | -6.8M | -99.0M |
| Cash Flow From Continuing Investing Activities | 426,000 | -719,000 | -6.8M | -99.0M |
| Issuance Of Debt | -- | 0.00 | 158,000 | 34,000 |
| Repayment Of Debt | -301,000 | -218,000 | -209,000 | -252,000 |
| Net Issuance Payments Of Debt | -301,000 | -218,000 | 158,000 | 34,000 |
| Issuance Of Capital Stock | 14.1M | 107.9M | 19.6M | 153.7M |
| Net Common Stock Issuance | 14.1M | 107.9M | 19.6M | 153.7M |
| Financing Cash Flow | 15.2M | 111.2M | 21.0M | 159.8M |
| Cash Flow From Continuing Financing Activities | 15.2M | 111.2M | 21.0M | 159.8M |
| Effect Of Exchange Rate Changes | 2.3M | 346,000 | 863,000 | -562,000 |
| Changes In Cash | -24.8M | 79.8M | -13.9M | 39.6M |
| Beginning Cash Position | 131.1M | 50.9M | 64.0M | 25.0M |
| End Cash Position | 108.5M | 131.1M | 50.9M | 64.0M |
| Free Cash Flow | -48.1M | -33.9M | -35.0M | -22.5M |
| Income Tax Paid Supplemental Data | -- | 0.00 | 0.00 | 0.00 |
| Interest Paid Supplemental Data | 5,000 | 4,000 | 6,000 | 2,000 |
| Change In Prepaid Assets | -524,000 | -253,000 | 129,000 | -183,000 |
| Common Stock Issuance | 14.1M | 107.9M | 19.6M | 153.7M |
| Depletion | -- | -- | 8.7M | 7.4M |
| Earnings Losses From Equity Investments | -16,000 | 4.4M | 2.9M | 464,000 |
| Gain Loss On Investment Securities | -- | -- | -22.0M | 6.7M |
| Gain Loss On Sale Of PPE | -162,000 | -1.3M | 25,000 | -135,000 |
| Long Term Debt Issuance | -- | 0.00 | 158,000 | 34,000 |
| Long Term Debt Payments | -301,000 | -218,000 | -209,000 | -252,000 |
| Net Business Purchase And Sale | -5.3M | -2.4M | -800,000 | -1.4M |
| Net Foreign Currency Exchange Gain Loss | -2.3M | -321,000 | -816,000 | 1.3M |
| Net Income From Continuing Operations | -91.1M | 90.4M | 14.4M | 19.0M |
| Net Long Term Debt Issuance | -301,000 | -218,000 | 158,000 | 34,000 |
| Net Other Financing Charges | -- | -218,000 | -209,000 | -252,000 |
| Net Other Investing Changes | -393,000 | -126,000 | 896,000 | -20.5M |
| Operating Gains Losses | -2.5M | 2.8M | -19.9M | 8.4M |
| Pension And Employee Benefit Expense | -- | -- | -- | -110,000 |
| Proceeds From Stock Option Exercised | 1.4M | 3.5M | 1.5M | 6.3M |
| Sale Of PPE | 240,000 | 125,000 | 12,000 | 139,000 |
| Unrealized Gain Loss On Investment Securities | 39.6M | -134.7M | -23.0M | -51.9M |